Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Assets (2023 - 2025)

Profound Medical has reported Non-Current Assets over the past 3 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $1.4 million for Q4 2025, up 18.56% from a year ago — trailing twelve months through Dec 2025 was $4.0 million (changed N/A YoY), and the annual figure for FY2025 was $1.4 million, up 18.56%.
  • Non-Current Assets for Q4 2025 was $1.4 million at Profound Medical, up from $781000.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for PROF hit a ceiling of $2.1 million in Q4 2023 and a floor of $781000.0 in Q3 2025.
  • Median Non-Current Assets over the past 3 years was $1.1 million (2024), compared with a mean of $1.2 million.
  • Biggest five-year swings in Non-Current Assets: plummeted 43.25% in 2024 and later grew 18.56% in 2025.
  • Profound Medical's Non-Current Assets stood at $2.1 million in 2023, then plummeted by 43.25% to $1.2 million in 2024, then rose by 18.56% to $1.4 million in 2025.
  • The last three reported values for Non-Current Assets were $1.4 million (Q4 2025), $781000.0 (Q3 2025), and $857000.0 (Q2 2025) per Business Quant data.